Registration successful.
Account activated – Pending validation
Your account has been activated successfully, but we still need to validate you as a UK healthcare professional. We’ll send you an email with the result. Please note this could take up to 10 days.
In the meantime, you can enjoy access to all the latest news, events and resources on our website.
Helping healthcare professionals to support patients
The updated Shingles Immunisation Programme one year on: What have we learnt?
This is a promotional webinar organised and funded by GSK for UK Healthcare professionals and other relevant decision makers only. This includes paid speaker(s).
Prescribing Information GB & NI
Adverse event reporting statement is at the foot of this page.
Join our expert-led webinars on 10th September at 18:30 or 12th September at 13:00 where we will be discussing best practice tips from one year of the updated Shingles Immunisation Programme.
August 2024 | PM-GB-SGX-WCNT-240026 (V1.0)
Quick links
Webinars & events
Featured products
Links to prescribing information at bottom of page.
More resources
Get more from GSKpro
Get access to free patient resources including demo devices, exclusive webinars on the topics that matter to you and more.
Prescribing information
Trelegy Ellipta prescribing information
Nucala prescribing information
Zejula prescribing information (GB)
Zejula prescribing information (NI)
SHINGRIX prescribing information (GB)
SHINGRIX prescribing information (NI)
Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk or search for MHRA Yellowcard in the Google Play or Apple App Store. Adverse events should also be reported to GSK on 0800 221 441 or UKSafety@gsk.com.
June 2024 | PM-GB-NA-WCNT-210014 (V9.0)
